BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 21176552)

  • 1. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
    Wang DP; Liang MY; Zhang XH; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maternal and perinatal outcomes in pregnant women with leukemia].
    Nomura RM; Igai AM; Faciroli NC; Aguiar IN; Zugaib M
    Rev Bras Ginecol Obstet; 2011 Aug; 33(8):174-81. PubMed ID: 22159617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
    Yadav U; Solanki SL; Yadav R
    J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery.
    Klamová H; Marková M; Moravcová J; Sisková M; Cetkovský P; Machová Poláková K
    Leuk Res; 2009 Nov; 33(11):1567-9. PubMed ID: 19580997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
    Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
    Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
    Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
    J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
    Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
    Cardonick E; Usmani A; Ghaffar S
    Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
    Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
    Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase.
    Warren E; Ward S; Gordois A; Scuffham P
    Clin Ther; 2004 Nov; 26(11):1924-33. PubMed ID: 15639704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematological malignancy and pregnancy: a single-institution experience of 21 cases.
    Dilek I; Topcu N; Demir C; Bay A; Uzun K; Gul A; Faik Oner A; Ugras S
    Clin Lab Haematol; 2006 Jun; 28(3):170-6. PubMed ID: 16706933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pregnancy outcome among patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].
    Jiang Q; Jiang B; Chen SS; Jiang H; Qin YZ; Lai YY; Shi HX; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):6-9. PubMed ID: 22575184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of risk factors for preeclampsia in pregnancies complicated with chronic aplastic anemia].
    Zhang C; Yin LY; Liang MY; Wang SM; Zhang XH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):422-6. PubMed ID: 22932107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelocytic leukemia in pregnancy: a case report describing successful treatment using multimodal therapy.
    Eskander RN; Tarsa M; Herbst KD; Kelly TF
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1731-3. PubMed ID: 21790885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
    Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Cortes J; Talpaz M; O'Brien S; Giles F; Beth Rios M; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Kantarjian H
    Cancer; 2003 Sep; 98(6):1105-13. PubMed ID: 12973833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant.
    Salomon O; Tohami T; Trakhtenbrot L; Meirov R; Kneller A; Berkowitz M; Nagler A; Sivan E; Goldman JM; Rechavi G; Amariglio N
    Leuk Res; 2010 Feb; 34(2):e78-81. PubMed ID: 19640586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful labor in the course of chronic lymphocytic leukemia (CLL) and management of CLL during pregnancy with leukapheresis.
    Ali R; Ozkalemkaş F; Ozkocaman V; Bülbül-Başkan E; Ozçelik T; Ozan U; Kimya Y; Tunali A
    Ann Hematol; 2004 Jan; 83(1):61-3. PubMed ID: 12961031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of eleven patients with chronic myeloproliferative disorders complicating pregnancy].
    Bai YT; Zhang C; Wang JL; Liang MY; Zhang XH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Dec; 45(12):896-9. PubMed ID: 21211419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of pediatric chronic myeloid leukemia in Sudan and hematological response to imatinib.
    Alkhatib MA
    Pediatr Hematol Oncol; 2011 Mar; 28(2):100-5. PubMed ID: 21083363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.